Glecaprevir/Pibrentasvir: First Global Approval
Crossref DOI link: https://doi.org/10.1007/s40265-017-0817-y
Published Online: 2017-09-19
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lamb, Yvette N.
License valid from 2017-09-19